Skip Nav Destination
Issues
1 July 2015
-
Cover Image
Cover Image
Mitotic progression was monitored by confocal fluorescence/differential interference contrast (DIC) images of time lapse from living MCF10A cells incubated in the presence of vehicle or 100 μM citral dimethyl acetal. The image series show chosen frames of images that were collected every 30 s. Hoechst 33258 was used to stain chromatin (blue). Please see the article by Lindström and colleagues (beginning on page 1073) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Review
Cell Cycle and Senescence
Cell Death and Survival
Chromatin, Gene, and RNA Regulation
Genomics
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration
Yuhong Wei; Ravi N. Vellanki; Étienne Coyaud; Vladimir Ignatchenko; Lei Li; Jonathan R. Krieger; Paul Taylor; Jiefei Tong; Nhu-An Pham; Geoffrey Liu; Brian Raught; Bradly G. Wouters; Thomas Kislinger; Ming Sound Tsao; Michael F. Moran
Oncogenes and Tumor Suppressors
SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer
Satoshi Ida; Nobuyuki Ozaki; Kimi Araki; Kotaro Hirashima; Yoko Zaitsu; Katsunobu Taki; Yasuo Sakamoto; Yuji Miyamoto; Eiji Oki; Masaru Morita; Masayuki Watanabe; Yoshihiko Maehara; Ken-ichi Yamamura; Hideo Baba; Masaki Ohmuraya
HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage–Associated Tumorigenesis
Lucie Janeckova; Vendula Pospichalova; Bohumil Fafilek; Martina Vojtechova; Jolana Tureckova; Jan Dobes; Marion Dubuissez; Dominique Leprince; Nikol Baloghova; Monika Horazna; Adela Hlavata; Jitka Stancikova; Eva Sloncova; Katerina Galuskova; Hynek Strnad; Vladimir Korinek
Signal Transduction
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds